UCLA 17th Annual UCLA Liver Diseases Symposium 2024

Includes: 8 Videos + 9 PDFs
Total Size: 2.69 GB

Overview

UCLA 17th Annual UCLA Liver Diseases Symposium 2024 is a comprehensive educational program that delivers the latest clinical updates in hepatology, liver transplantation, cirrhosis, portal hypertension, hepatocellular carcinoma (HCC), metabolic dysfunction-associated steatotic liver disease (MASLD), primary biliary cholangitis (PBC), and drug-induced liver injury (DILI).

Presented by leading UCLA faculty and multidisciplinary experts, this symposium combines evidence-based lectures with real-world clinical case discussions to help healthcare professionals improve the diagnosis, risk assessment, and treatment of patients with acute and chronic liver diseases. Participants will gain practical insights into current treatment guidelines, transplant eligibility, interventional radiology techniques, and emerging therapies that can be immediately applied in clinical practice.

Whether caring for patients with advanced cirrhosis, liver cancer, alcohol-related liver disease, or acute liver failure, this course provides up-to-date recommendations supported by current research and expert consensus.

Learning Objectives

After completing this course, participants will be able to:

• Diagnose and manage patients with advanced liver disease using current evidence-based recommendations.
• Improve prognostic assessment and risk stratification before invasive procedures and surgery.
• Understand the latest evaluation, listing, and organ allocation process for liver transplantation.
• Identify appropriate candidates for interventional radiology procedures in portal hypertension.
• Apply modern management strategies for hepatocellular carcinoma (HCC).
• Integrate recently approved therapies for primary biliary cholangitis (PBC) into clinical practice.
• Evaluate and manage autoimmune hepatitis using current treatment approaches.
• Assess patients with metabolic dysfunction-associated steatotic liver disease (MASLD) and develop individualized management plans.
• Optimize multidisciplinary care for alcohol-associated liver disease and alcohol hepatitis.
• Recognize common causes of drug-induced liver injury (DILI) and identify patients at risk for severe outcomes.
• Diagnose acute liver failure, determine prognosis, and recognize when liver transplantation is indicated.

Course Topics

• Changes in Evaluation, Listing, and Organ Allocation in Liver Transplantation
• Current Evaluation and Treatment of Metabolic Dysfunction Associated Liver Disease
• Evaluating-Induced Liver Injury – When to be Concerned
• Multidisciplinary Approach for Patients with Alcohol Liver Disease Including Those with Alcohol Hepatitis – Perspectives from Hepatology and Addiction Medicine
• New Concepts in Portal Hypertension and Risk Stratification of Patients with Liver Cirrhosis
• New Therapies in Primary Biliary Cholangitis and Approaches in Autoimmune Hepatitis
• Panel Case Discussion Multi-Disciplinary Approach to Liver Cancer
• Panel Discussion- Acute on Chronic and Fulminant Liver Failure
• Radiologic Treatment of Refractory Hepatic Encephalopathy, Ascites, and Variceal Bleeding

Why You Should Take This Course

• Learn directly from UCLA experts in hepatology and liver transplantation.
• Stay current with the latest clinical guidelines and evidence-based therapies.
• Improve diagnostic accuracy and patient risk stratification.
• Master contemporary management of cirrhosis, portal hypertension, liver cancer, MASLD, and autoimmune liver diseases.
• Enhance multidisciplinary decision-making through expert case discussions.
• Apply practical knowledge immediately to everyday clinical practice.

Course Details

Course Name: UCLA 17th Annual UCLA Liver Diseases Symposium 2024

Format: 8 Videos + 9 PDF Files

Total Size: 2.69 GB

Event Date: October 26, 2024

Location: Hyatt Regency Westlake, Westlake, California, USA